Your browser doesn't support javascript.
loading
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Yeo, Yee Hui; Tseng, Tai-Chung; Hosaka, Tetsuya; Cunningham, Chris; Fung, James Yan Yue; Ho, Hsiu J; Kwak, Min-Sun; Trinh, Huy N; Ungtrakul, Teerapat; Yu, Ming-Lung; Kobayashi, Mariko; Le, An K; Henry, Linda; Li, Jiayi; Zhang, Jian; Sriprayoon, Tassanee; Jeong, Donghak; Tanwandee, Tawesak; Gane, Ed; Cheung, Ramsey C; Wu, Chun-Ying; Lok, Anna S; Lee, Hyo-Suk; Suzuki, Fumitaka; Yuen, Man-Fung; Kao, Jia-Horng; Yang, Hwai-I; Nguyen, Mindie H.
Afiliação
  • Yeo YH; Department of Medicine, Stanford University Medical Center, Palo Alto, California, USA.
  • Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hosaka T; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Cunningham C; Research Centre for Maori Health and Development, Massey University, Wellington, New Zealand.
  • Fung JYY; The Hepatitis Foundation of New Zealand, Whakatane, New Zealand.
  • Ho HJ; Department of Medicine, The University of Hong Kong, Hong Kong, China.
  • Kwak MS; Division of Translational Research, Taipei Veterans General Hospital, Taipei City, Taiwan.
  • Trinh HN; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Ungtrakul T; San Jose Gastroenterology, San Jose, California, USA.
  • Yu ML; Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Kobayashi M; Hepatobiliary Section, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Le AK; Center for Liver Research, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Henry L; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Li J; Research Institute for Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Zhang J; Department of Medicine, Stanford University Medical Center, Palo Alto, California, USA.
  • Sriprayoon T; Department of Medicine, Stanford University Medical Center, Palo Alto, California, USA.
  • Jeong D; Palo Alto Medical Foundation, Mountain View Division, Palo Alto, California, USA.
  • Tanwandee T; Chinese Hospital, San Francisco, California, USA.
  • Gane E; School of Nursing, University of California, San Francisco, San Francisco, California, USA.
  • Cheung RC; Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Wu CY; Department of Medicine, Stanford University Medical Center, Palo Alto, California, USA.
  • Lok AS; Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Lee HS; New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand.
  • Suzuki F; Department of Medicine, University of Auckland, Auckland, New Zealand.
  • Yuen MF; Department of Medicine, Stanford University Medical Center, Palo Alto, California, USA.
  • Kao JH; Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
  • Yang HI; Division of Translational Research, Taipei Veterans General Hospital, Taipei City, Taiwan.
  • Nguyen MH; College of Public Health, China Medical University, Taichung, Taiwan.
Clin Transl Gastroenterol ; 11(9): e00196, 2020 09.
Article em En | MEDLINE | ID: mdl-33094953
ABSTRACT

INTRODUCTION:

Spontaneous hepatitis B surface antigen (HBsAg) seroclearance, the functional cure of hepatitis B infection, occurs rarely. Prior original studies are limited by insufficient sample size and/or follow-up, and recent meta-analyses are limited by inclusion of only study-level data and lack of adjustment for confounders to investigate HBsAg seroclearance rates in most relevant subgroups. Using a cohort with detailed individual patient data, we estimated spontaneous HBsAg seroclearance rates through patient and virologic characteristics.

METHODS:

We analyzed 11,264 untreated patients with chronic hepatitis B with serial HBsAg data from 4 North American and 8 Asian Pacific centers, with 1,393 patients with HBsAg seroclearance (≥2 undetectable HBsAg ≥6 months apart) during 106,192 person-years. The annual seroclearance rate with detailed categorization by infection phase, further stratified by hepatitis B e antigen (HBeAg) status, sex, age, and quantitative HBsAg (qHBsAg), was performed.

RESULTS:

The annual seroclearance rate was 1.31% (95% confidence interval 1.25-1.38) and over 7% in immune inactive patients aged ≥55 years and with qHBsAg <100 IU/mL. The 5-, 10-, 15-, and 20-year cumulative rates were 4.74%, 10.72%, 18.80%, and 24.79%, respectively. On multivariable analysis, male (adjusted hazard ratio [aHR] = 1.66), older age (41-55 years aHR = 1.16; >55 years aHR = 1.21), negative HBeAg (aHR = 6.34), and genotype C (aHR = 1.82) predicted higher seroclearance rates, as did lower hepatitis B virus DNA and lower qHBsAg (P < 0.05 for all), and inactive carrier state.

DISCUSSION:

The spontaneous annual HBsAg seroclearance rate was 1.31%, but varied from close to zero to about 5% among most chronic hepatitis B subgroups, with older, male, HBeAg-negative, and genotype C patients with lower alanine aminotransferase and hepatitis B virus DNA, and qHBsAg independently associated with higher rates (see Visual Abstract, Supplementary Digital Content 2, http//links.lww.com/CTG/A367).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Hepatite B Crônica / Antígenos de Superfície da Hepatite B Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Hepatite B Crônica / Antígenos de Superfície da Hepatite B Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article